Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Other Non Operating Income (2022)

Updated

Oruka Therapeutics' Other Non Operating Income came in at $5,000 for FY2022.

Analysis

Oruka Therapeutics (ORKA) Other Non Operating Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Oruka Therapeutics 5.31 Bn 3.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 3,000.00
Mar 31, 2022 2,000.00
API Access

Oruka Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ORKA&period=max&api_key=YOUR_API_KEY